Screener
Castle Biosciences CSTL Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on trailing twelve months.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's asset turnover?
- Castle Biosciences (CSTL) reported asset turnover of 0.6× in Q1 2026.
- How has Castle Biosciences's asset turnover changed year-over-year?
- Castle Biosciences's asset turnover decreased by 10.4% year-over-year, from 0.7× to 0.6×.
- What is the long-term trend for Castle Biosciences's asset turnover?
- Over 5 years (2020 to 2025), Castle Biosciences's asset turnover has grown at a 22.6% compound annual growth rate (CAGR), from 0.2× to 0.6×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Castle Biosciences's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude